During the pandemic, our client, a global pharmaceutical leader, needed to optimise its COVID-19 vaccine production and delivery processes. Our client had to rapidly implement business applications in order to increase production efficiency.
In response to an unprecedented global pandemic, our client – one of the pharma industry leaders- set out to develop, test, mass produce and organize the global distribution of a COVID-19 vaccine.
Availability of ICUs is one of the key factors to keep the death toll as low as possible. ICU-M has been one of the reasons Germany has been managing the pandemic relatively well, keeping the number of deaths per 1M population at the low end compared with other EU states.